CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Target Antigen (CD19/CD22, BCMA, and Others); By Indication; By Region; Segment Forecast, 2023

Description

List of Tables

The global CAR-T cell therapy market size is expected to reach USD 118,680.68 million by 2032, according to a new study by Polaris Market Research. The report "CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Target Antigen (CD19/CD22, BCMA, and Others); By Indication; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The CAR-T cell therapy market is experiencing significant growth as it utilizes the immune system to combat cancer. This groundbreaking approach involves modifying a patient's own T cells, a type of white blood cell, to express chimeric antigen receptors (CARs) on their surface. These CARs enable the T cells to recognize and target specific antigens in cancer cells, leading to their destruction. CAR-T therapy has shown promising results in treating specific blood malignancies and is being explored for its potential in other types of cancer.

In CAR-T treatment, T cells from the patient's blood are taken out and genetically modified in a lab to produce receptors that bind to proteins prevalent in cancer cells. Large quantities of these modified CAR-T cells are then produced and administered to the patient. By enhancing the T cells' ability to locate and attack cancer cells, CAR-T therapy has the potential to revolutionize cancer treatment.

However, the COVID-19 pandemic has impacted the CAR-T cell therapy market. Lockdowns and disruptions in the supply chain have resulted in delays and interruptions in the production and availability of raw materials needed for CAR-T cell manufacturing. This has created challenges for life science and biopharma companies, causing them to wait for new raw materials for CAR-T cell production. Efforts are underway to address these supply chain issues and ensure a steady supply of materials to support the manufacturing of CAR-T cells during these challenging times.

CAR-T Cell Therapy Market Report Highlights

CD19/CD22 is the CAR-T cell therapy with the largest market share. It has shown remarkable clinical results in leukemia and lymphoma treatment, gaining regulatory approval and proving effective in achieving patient remission.

DLBCL (Diffuse Large B-cell Lymphoma) is a prominent indication in the CAR-T cell therapy market, holding a significant market share. This fast-growing cancer of B-cell origin is a prevalent form of non-Hodgkin lymphoma affecting the lymphatic system.

North America is set to lead the market, driven by rising cancer incidence and the growing biotechnology industry. The region's demand for cancer treatments is increasing accordingly.

The global key market players include: Amgen Inc. (US), Bellicum Pharmaceuticals, Inc. (US), Bluebird Bio (US), Caribou Biosciences, Inc. (US), Celgene Corporation, Cellectis, Celyad, Gilead Sciences, Inc., Intellia Therapeutics, Johnson & Johnson, Merck KGaA, Nanjing Legend Biotechnology Co., Ltd., Noile-Immune Biotech, Novartis International AG, Pfizer Inc., Sangamo Therapeutics, Inc., Servier Laboratories.

Polaris Market Research has segmented the CAR-T Cell Therapy market report based on target antigen, indication, and region:

CAR-T Cell Therapy, Target Antigen Outlook (Revenue - USD Million, 2019 - 2032)

CD19/CD22
BCMA (B-Cell Maturation Antigen)
Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY)

CAR-T Cell Therapy, Indication Outlook (Revenue - USD Million, 2019 - 2032)

DLBCL
ALL
CLL
MM
FL
Mastozytosis
Myeloid Fibrosis
MLL
Thymic Cancer
Glioblastoma
AML
Others

CAR-T Cell Therapy, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Austria
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Rest of Middle East & Africa

Product Code: PM1389

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global CAR-T Cell Therapy Market Insights

4.1. CAR-T Cell Therapy Market - Industry Snapshot
4.2. CAR-T Cell Therapy Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rise in awareness regarding CAR T-cell therapy
  - 4.2.1.2. Increase in demand of ideal therapeutics for treatment of cancer
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost of CAR T-cell therapies
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. CAR-T Cell Therapy Industry trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global CAR-T Cell Therapy Market, by Target Antigen

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global CAR-T Cell Therapy, by Target Antigen, 2019-2032 (USD Million)
5.3. CD19/CD22
- 5.3.1. Global CAR-T Cell Therapy Market, by CD19/CD22, by Region, 2019-2032 (USD Million)
5.4. BCMA (B-Cell Maturation Antigen)
- 5.4.1. Global CAR-T Cell Therapy Market, by BCMA (B-Cell Maturation Antigen), by Region, 2019-2032 (USD Million)
5.5. Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY)
- 5.5.1. Global CAR-T Cell Therapy Market, by Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY), by Region, 2019-2032 (USD Million)

6. Global CAR-T Cell Therapy Market, by Indication

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
6.3. DLBCL
- 6.3.1. Global CAR-T Cell Therapy Market, by DLBCL, by Region, 2019-2032 (USD Million)
6.4. ALL
- 6.4.1. Global CAR-T Cell Therapy Market, by ALL, by Region, 2019-2032 (USD Million)
6.5. CLL
- 6.5.1. Global CAR-T Cell Therapy Market, by CLL, by Region, 2019-2032 (USD Million)
6.6. MM
- 6.6.1. Global CAR-T Cell Therapy Market, by MM, by Region, 2019-2032 (USD Million)
6.7. FL
- 6.7.1. Global CAR-T Cell Therapy Market, by FL, by Region, 2019-2032 (USD Million)
6.8. Mastozytosis
- 6.8.1. Global CAR-T Cell Therapy Market, by Mastozytosis, by Region, 2019-2032 (USD Million)
6.9. Myeloid Fibrosis
- 6.9.1. Global CAR-T Cell Therapy Market, by Myeloid Fibrosis, by Region, 2019-2032 (USD Million)
6.10. MLL
- 6.10.1. Global CAR-T Cell Therapy Market, by MLL, by Region, 2019-2032 (USD Million)
6.11. Thymic Cancer
- 6.11.1. Global CAR-T Cell Therapy Market, by Thymic Cancer, by Region, 2019-2032 (USD Million)
6.12. Glioblastoma
- 6.12.1. Global CAR-T Cell Therapy Market, by Glioblastoma, by Region, 2019-2032 (USD Million)
6.13. AML
- 6.13.1. Global CAR-T Cell Therapy Market, by AML, by Region, 2019-2032 (USD Million)
6.14. Others
- 6.14.1. Global CAR-T Cell Therapy Market, by Others, by Region, 2019-2032 (USD Million)

7. Global CAR-T Cell Therapy Market, by Geography

7.1. Key findings
7.2. Introduction
- 7.2.1. CAR-T Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Million)
7.3. CAR-T Cell Therapy Market - North America
- 7.3.1. North America: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
- 7.3.2. North America: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.3.3. CAR-T Cell Therapy Market - U.S.
  - 7.3.3.1. U.S.: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.3.3.2. U.S.: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.3.4. CAR-T Cell Therapy Market - Canada
  - 7.3.4.1. Canada: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.3.4.2. Canada: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
7.4. CAR-T Cell Therapy Market - Europe
- 7.4.1. Europe: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
- 7.4.2. Europe: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.4.3. CAR-T Cell Therapy Market - UK
  - 7.4.3.1. UK: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.4.3.2. UK: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.4.4. CAR-T Cell Therapy Market - France
  - 7.4.4.1. France: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.4.4.2. France: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.4.5. CAR-T Cell Therapy Market - Germany
  - 7.4.5.1. Germany: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.4.5.2. Germany: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.4.6. CAR-T Cell Therapy Market - Italy
  - 7.4.6.1. Italy: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.4.6.2. Italy: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.4.7. CAR-T Cell Therapy Market - Spain
  - 7.4.7.1. Spain: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.4.7.2. Spain: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.4.8. CAR-T Cell Therapy Market - Netherlands
  - 7.4.8.1. Netherlands: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.4.8.2. Netherlands: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.4.9. CAR-T Cell Therapy Market - Russia
  - 7.4.9.1. Russia: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.4.9.2. Russia: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
7.5. CAR-T Cell Therapy Market - Asia Pacific
- 7.5.1. Asia Pacific: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
- 7.5.2. Asia Pacific: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.5.3. CAR-T Cell Therapy Market - China
  - 7.5.3.1. China: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.5.3.2. China: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.5.4. CAR-T Cell Therapy Market - India
  - 7.5.4.1. India: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.5.4.2. India: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.5.5. CAR-T Cell Therapy Market - Malaysia
  - 7.5.5.1. Malaysia: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.5.5.2. Malaysia: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.5.6. CAR-T Cell Therapy Market - Japan
  - 7.5.6.1. Japan: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.5.6.2. Japan: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.5.7. CAR-T Cell Therapy Market - Indonesia
  - 7.5.7.1. Indonesia: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.5.7.2. Indonesia: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.5.8. CAR-T Cell Therapy Market - South Korea
  - 7.5.8.1. South Korea: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.5.8.2. South Korea: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
7.6. CAR-T Cell Therapy Market - Middle East & Africa
- 7.6.1. Middle East & Africa: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
- 7.6.2. Middle East & Africa: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.6.3. CAR-T Cell Therapy Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.6.3.2. Saudi Arabia: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.6.4. CAR-T Cell Therapy Market - UAE
  - 7.6.4.1. UAE: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.6.4.2. UAE: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.6.5. CAR-T Cell Therapy Market - Israel
  - 7.6.5.1. Israel: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.6.5.2. Israel: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.6.6. CAR-T Cell Therapy Market - South Africa
  - 7.6.6.1. South Africa: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.6.6.2. South Africa: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
7.7. CAR-T Cell Therapy Market - Latin America
- 7.7.1. Latin America: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
- 7.7.2. Latin America: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.7.3. CAR-T Cell Therapy Market - Mexico
  - 7.7.3.1. Mexico: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.7.3.2. Mexico: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.7.4. CAR-T Cell Therapy Market - Brazil
  - 7.7.4.1. Brazil: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.7.4.2. Brazil: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
- 7.7.5. CAR-T Cell Therapy Market - Argentina
  - 7.7.5.1. Argentina: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
  - 7.7.5.2. Argentina: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Amgen Inc. (US)
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Bellicum Pharmaceuticals, Inc
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Bellicum Pharmaceuticals, Inc. (US)
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Bluebird Bio (US)
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Caribou Biosciences, Inc. (US)
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Cellectis
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Celyad
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Gilead Sciences, Inc.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Intellia Therapeutics
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Johnson & Johnson
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Merck KGaA
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
9.12. Nanjing Legend Biotechnology Co., Ltd
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
9.13. Noile-Immune Biotech
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
9.14. Novartis International AG
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
9.15. Pfizer Inc
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
9.16. Sangamo Therapeutics, Inc
- 9.16.1. Company Overview
- 9.16.2. Financial Performance
- 9.16.3. Product Benchmarking
- 9.16.4. Recent Development
9.17. Servier Laboratories
- 9.17.1. Company Overview
- 9.17.2. Financial Performance
- 9.17.3. Product Benchmarking
- 9.17.4. Recent Development

Product Code: PM1389

List of Tables

Table 1 Global CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 2 Global CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 3 CAR-T Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Million)
Table 4 North America: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 5 North America: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 6 U.S.: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 7 U.S.: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 8 Canada: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 9 Canada: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 10 Europe: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 11 Europe: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 12 UK: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 13 UK: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 14 France: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 15 France: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 16 Germany: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 17 Germany: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 18 Italy: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 19 Italy: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 20 Spain: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 21 Spain: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 22 Netherlands: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 23 Netherlands: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 24 Russia: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 25 Russia: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 26 Asia Pacific: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 27 Asia Pacific: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 28 China: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 29 China: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 30 India: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 31 India: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 32 Malaysia: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 33 Malaysia: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 34 Japan: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 35 Japan: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 36 Indonesia: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 37 Indonesia: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 38 South Korea: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 39 South Korea: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 40 Middle East & Africa: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 41 Middle East & Africa: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 42 Saudi Arabia: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 43 Saudi Arabia: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 44 UAE: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 45 UAE: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 46 Israel: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 47 Israel: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 48 South Africa: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 49 South Africa: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 50 Latin America: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 51 Latin America: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 52 Mexico: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 53 Mexico: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 54 Brazil: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 55 Brazil: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)
Table 56 Argentina: CAR-T Cell Therapy Market, by Indication, 2019-2032 (USD Million)
Table 57 Argentina: CAR-T Cell Therapy Market, by Target Antigen, 2019-2032 (USD Million)

List of Figures

Figure 1 Global CAR-T Cell Therapy Market, 2019-2032 (USD Million)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
Figure 4 Market by Geography
Figure 5 Porter's Five Forces
Figure 6 Market by Indication
Figure 7 Global CAR-T Cell Therapy Market, by Indication, 2022 & 2032 (USD Million)
Figure 8 Market by Target Antigen
Figure 9 Global CAR-T Cell Therapy Market, by Target Antigen, 2022 & 2032 (USD Million)
Figure 10 CAR-T Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Million)
Figure 11 Strategic Analysis - CAR-T Cell Therapy Market

CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Target Antigen (CD19/CD22, BCMA, and Others); By Indication; By Region; Segment Forecast, 2023 - 2032

Description

Table of Contents

List of Tables

CAR-T Cell Therapy Market Report Highlights

CAR-T Cell Therapy, Target Antigen Outlook (Revenue - USD Million, 2019 - 2032)

CAR-T Cell Therapy, Indication Outlook (Revenue - USD Million, 2019 - 2032)

CAR-T Cell Therapy, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global CAR-T Cell Therapy Market Insights

5. Global CAR-T Cell Therapy Market, by Target Antigen

6. Global CAR-T Cell Therapy Market, by Indication

7. Global CAR-T Cell Therapy Market, by Geography

8. Competitive Landscape

9. Company Profiles

List of Tables

List of Figures